In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention
Table 1
The baseline characteristics and laboratory results of patients classified according to no-reflow.
Normal reflow ()
No-reflow ()
value
Age (years)
0.004
Female gender
19 (15.8%)
24 (16.9%)
0.816
Hypertension
51 (42.5%)
84 (59.2%)
<0.001
Smoking
32 (26.7%)
43 (30.3%)
0.519
Family history of CAD
28 (23.3%)
39 (27.5%)
0.445
Heart rate (bpm)
0.085
Systolic blood pressure (mmHg)
0.294
Diastolic blood pressure (mmHg)
0.366
Admission LVEF (%)
0.135
In-hospital peak glycemia (g/L)
<0.001
Admission glucose (g/L)
0.024
Killip on admission
21 (17.5%)
38 (26.8%)
0.013
White blood cell count (103/μL)
0.004
Estimated GFR (mL/min/1.73 m2)
0.026
Hemoglobin (g/dL)
0.218
TC (mg/dL)
0.541
TG (mg/dL)
0.008
LDL-C (mg/dL)
0.094
HDL-C (mg/dL)
0.227
Peak cTnI (U/L)
0.308
Peak CK-MB (U/L)
91.5 (65.3–108.7)
135.2 (73.5–196.6)
<0.001
C-reactive protein (mg/dL)
9.4 (5.3–18.1)
14.3 (7.6–27.2)
0.005
CAD: coronary artery disease; LEVF: left ventricular ejection fraction; GFR: glomerular filtration rate; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; cTnI: cardiac troponin I; CK-MB: creatine kinase myocardial band. The data presented are or (percentage) or median (95% confidence interval (CI)). The comparison of data between the two groups was done by the Student test or Fisher’s exact test.
